Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 7101-7110 Newer>

The Motley Fool April 28, 2005 Stephen D. Simpson	Glaxo Works to Stay on Track With FDA issues near resolution, Glaxo should continue its respectable growth trajectory. Investors looking at the pharmaceutical space would do well to at least consider this stock.
The Motley Fool April 28, 2005 Mike Cianciolo	A Polished Applebee's The restaurant company maintains its diet of steady growth. Investors looking for a reliable, though not flashy, performer may want to consider Applebee's.
The Motley Fool April 28, 2005 Brian Gorman	PPD Branches Out The company, which concentrates on running clinical trials for pharmaceutical and biotech clients is right in diversifying, but its strategy carries its own risk.
The Motley Fool April 28, 2005 Lawrence Meyers	Ethan Allen Takes a Seat Fine furniture doesn't translate to big stock returns.
The Motley Fool April 28, 2005 Stephen D. Simpson	Bristol-Myers: Hang in There Generics are wreaking havoc on growth, but patient investors can pin hopes on drugs now in the pipeline.
The Motley Fool April 28, 2005 Rich Smith	When to Sell a Winner Buying cheap stocks is relatively easy. Knowing when to sell them after they're no longer screaming bargains is hard. The good news, however, is that you really rarely need to sell at all.
The Motley Fool April 28, 2005 Jeff Hwang	Starbucks Hits the Mark Second-quarter results meet expectations. Is it time to buy?
The Motley Fool April 28, 2005 Tom Taulli	Shopping.com Until the Stock Drops It's a competitive world for online shopping sites, and that's putting pressure on profits for Shopping.com. Investors, take note.
The Motley Fool April 28, 2005 Rich Smith	Analysts Running Scared When analysts say "buy," the object of their affection tanks. When they say "sell," it's up, up, and away. It makes an investor wonder: Is all of Wall Street just one big contrarian indicator?
The Motley Fool April 28, 2005 Lawrence Meyers	Is Brink's a Secure Investment? Lots of spending and a confusing 10-K make this company less attractive than it first appears.
<Older 7101-7110 Newer> Return to current articles.